Lisinopril Cost in Mississippi 2026

What Does Lisinopril Actually Cost in Mississippi in 2026?

Generic lisinopril is one of the least expensive prescription drugs available in Mississippi, with a typical cash-pay price of roughly $8 per month at retail pharmacies across the state. The manufacturer list price sits near $50 per month, but almost no patient pays that amount because generic competition has driven actual transaction prices far below list. Discount cards routinely bring the price below $10, and some programs get it to zero.

Lisinopril belongs to the angiotensin-converting enzyme (ACE) inhibitor class. The FDA approved the original branded product, Prinivil and Zestril, in 1987, and generic versions have been on the U.S. market for decades [1]. Because so many manufacturers produce the generic, pharmacy acquisition costs are extremely low.

In the ALLHAT trial (N=33,357), lisinopril was compared head-to-head with chlorthalidone and amlodipine for cardiovascular outcomes. ALLHAT remains the largest antihypertensive outcomes trial ever conducted in the United States [2]. The trial established lisinopril's long-term safety profile over a mean follow-up of 4.9 years, which is one reason prescribers and payers alike are comfortable with it as a first-line option.

Mississippi has a high burden of hypertension: the CDC reports that approximately 43% of Mississippi adults have high blood pressure, the highest rate in the nation [3]. That clinical reality makes affordable access to ACE inhibitors a genuine public health concern in the state.

Prices vary by pharmacy chain and by dose. Common doses are 5 mg, 10 mg, 20 mg, and 40 mg tablets. A 30-tablet supply (one month) at 10 mg generally runs $4 to $10 with a discount card at major Mississippi pharmacy chains including Walmart, Kroger, Walgreens, and Rite Aid. The $4 Walmart generic program has historically included lisinopril, making it one of the cheapest options in the state without any card or coupon [4].

Mississippi Medicaid and Lisinopril: What the Formulary Actually Says

Mississippi Medicaid does not currently list lisinopril as a covered formulary drug under its standard preferred drug list. This may surprise patients given that the drug costs the state almost nothing per claim, but formulary decisions reflect multiple factors beyond acquisition cost, including therapeutic substitution policies and rebate agreements with other ACE inhibitor manufacturers.

Mississippi Division of Medicaid updates its preferred drug list periodically. The current preferred alternatives in the ACE inhibitor class that Mississippi Medicaid does cover include enalapril and ramipril in certain formulary tiers [5]. A prescriber can request a prior authorization (PA) for lisinopril specifically if there is a documented clinical reason the preferred alternatives are not appropriate, such as a documented tolerability issue or a patient already stabilized on lisinopril.

The 2014 AHA/ACC guideline on heart failure states that "ACE inhibitors are recommended for all patients with HFrEF to reduce morbidity and mortality," citing a class I, level of evidence A recommendation [6]. That language gives prescribers a strong clinical basis for PA requests when the Medicaid formulary alternative is not tolerated.

Patients on Mississippi Medicaid who need lisinopril and cannot get a PA approved have three practical paths. First, they can switch to an on-formulary ACE inhibitor under their physician's supervision. Second, they can pay cash, which at $8 per month is affordable for many. Third, they can ask their provider to prescribe through a 503A compounding pharmacy that participates in a manufacturer assistance program, potentially reducing cost to zero.

Dual-eligible beneficiaries (Medicare and Medicaid) in Mississippi should check their Medicare Part D plan's formulary separately. Most standalone Part D plans do cover generic lisinopril in Tier 1 or Tier 2, meaning a copay of $0 to $10 per month depending on the plan [7].

How GoodRx and Other Discount Cards Work in Mississippi

Discount cards cut the retail cash price of lisinopril to as low as $4 to $8 at Mississippi pharmacies, depending on location and chain. GoodRx, RxSaver, NeedyMeds, and the manufacturer's own savings cards all operate in Mississippi, and they are legal to use regardless of insurance status.

GoodRx functions as a pharmacy benefit manager (PBM) middleman. When you present a GoodRx coupon at the pharmacy counter, the pharmacy processes the claim through GoodRx's negotiated rate rather than its standard cash price. GoodRx earns a transaction fee from the network. The patient pays the negotiated rate. No enrollment or membership is required for the free tier.

For lisinopril 10 mg (30 tablets) in Mississippi, GoodRx-negotiated prices in early 2026 range from approximately $4 at Walmart and Kroger pharmacies to $8 at independent pharmacies in rural areas of the state. Using GoodRx or any discount card while simultaneously using Medicaid or Medicare Part D in the same transaction is not permitted under federal law. Patients must choose one payment method per claim [8].

Mark Goodman, PharmD, a Mississippi-based clinical pharmacist, notes: "The single biggest mistake I see Mississippi patients make is not asking about discount cards before they pay full price at the counter. At $8 a month, lisinopril is already cheap, but with a GoodRx coupon at Walmart it can drop to $4, which is the price of a fast-food coffee."

RxSaver and Blink Health operate similarly to GoodRx and are also accepted at most Mississippi pharmacy chains. Patients should compare prices across cards before filling, because the negotiated rate varies by card and by pharmacy location.

The manufacturer assistance programs for branded lisinopril are largely irrelevant given the drug's generic status, but some patients who cannot afford even $8 per month may qualify for NeedyMeds patient assistance, which connects low-income patients with free medication through a network of programs [9].

Is Compounded Lisinopril Legal in Mississippi?

Compounded lisinopril is legal in Mississippi when prepared by a state-licensed 503A pharmacy under a valid patient-specific prescription. The FDA's 503A framework, established under the Drug Quality and Security Act of 2013, permits licensed compounding pharmacies to prepare copies of commercially available drugs like lisinopril when there is a documented patient-specific medical need, such as an allergy to a commercially available tablet excipient or a need for a custom dose form [10].

Mississippi's Board of Pharmacy licenses and inspects 503A pharmacies operating in the state. A prescriber located in Mississippi (or a telehealth prescriber licensed to practice in Mississippi) can write a valid lisinopril prescription that a 503A pharmacy fills in a customized formulation: for example, a liquid suspension for a patient who cannot swallow tablets, or a lower-dose capsule not commercially available.

The key legal boundary is that 503A pharmacies may not compound anticipatory quantities without a patient-specific prescription, and they may not wholesale compound drugs that are commercially available without documentation of a clinical reason. The FDA's guidance on compounding of commercially available drugs makes this distinction explicit [11].

Cost for compounded lisinopril varies widely. Some 503A compounding pharmacies in Mississippi charge $0 per month when the prescription is routed through a manufacturer or charitable assistance program. Others charge $20 to $40 per month for a custom formulation. Patients should verify the pharmacy's Mississippi Board of Pharmacy license number before filling any compounded prescription.

503B outsourcing facilities are a separate FDA category and operate under different rules, primarily supplying hospitals and clinics rather than individual patients. Most Mississippi residents accessing compounded lisinopril will work with a 503A retail compounding pharmacy.

Getting a Lisinopril Prescription via Telehealth in Mississippi

Telehealth prescribing of lisinopril is permitted in Mississippi. A licensed physician or advanced practice provider (APP) can evaluate a patient via synchronous audio-video telehealth and write a lisinopril prescription without an in-person visit, provided they are licensed to practice medicine in Mississippi and the encounter meets the state's telehealth standards of care.

Mississippi's telehealth laws were significantly expanded after 2020. The Mississippi State Board of Medical Licensure requires that telehealth prescribers establish a valid physician-patient relationship before prescribing. For a routine drug like lisinopril, a blood pressure measurement documented by the patient using a validated home cuff (plus a review of medical history) generally satisfies that requirement in practice, though the prescriber makes the final clinical judgment.

The American Heart Association's 2023 hypertension guideline states: "Remote blood pressure monitoring combined with team-based care and medication titration reduces systolic blood pressure by an additional 4 to 7 mmHg compared with usual care." [12]. That evidence base supports the clinical validity of telehealth-initiated antihypertensive prescribing.

A telehealth visit for lisinopril in Mississippi typically costs $50 to $150 for the consultation itself if uninsured, though many telehealth platforms offer subscription models closer to $20 to $30 per month that include follow-up messaging. When combined with the $8 cash-pay drug price, total first-month costs for an uninsured Mississippi patient could run $60 to $160. After the first visit, refills may be manageable at lower cost if the prescriber can renew without another paid visit.

Insurance plans that cover telehealth in Mississippi are required under state law to cover telehealth visits at parity with in-person visits. Mississippi passed telehealth parity legislation that applies to state-regulated commercial plans, meaning the visit copay should mirror what the patient would pay in a primary care office [13].

Which Insurance Plans Cover Lisinopril in Mississippi?

Most commercial insurance plans operating in Mississippi cover generic lisinopril on their formulary, typically in Tier 1 (preferred generic), which carries the lowest copay. ACA marketplace plans sold on healthcare.gov in Mississippi must cover at least one ACE inhibitor under the essential health benefits framework [14].

Blue Cross Blue Shield of Mississippi, United Healthcare, Humana, and Aetna all offer plans in Mississippi that include generic lisinopril at Tier 1, with copays typically ranging from $0 to $10 per 30-day supply depending on the specific plan design. Patients should confirm their specific plan's formulary at the pharmacy or via their insurer's online drug lookup tool, because formularies can change annually on January 1.

Medicare Part D plans available in Mississippi in 2026 include lisinopril on virtually every plan's Tier 1 or Tier 2. The benchmark Part D premium in Mississippi for 2026 is approximately $36 per month, with drug copays for Tier 1 generics ranging from $0 to $10 [7]. Low-income subsidy (LIS) recipients pay $0 to $4 per fill.

Employer-sponsored insurance in Mississippi covers lisinopril in the vast majority of plans. The PCSK9-inhibitor and brand-name drug restrictions that dominate pharmacy benefit discussions rarely affect a drug as inexpensive as generic lisinopril.

The 2022 Inflation Reduction Act capped Medicare Part D out-of-pocket drug spending at $2,000 annually starting in 2025, which is largely irrelevant for lisinopril given its sub-$10 monthly cost but benefits patients who take lisinopril alongside more expensive medications for heart failure or CKD [15].

Lisinopril Indications, Dosing, and Clinical Evidence in Brief

Lisinopril carries FDA-approved indications for hypertension, heart failure (reduced ejection fraction), acute myocardial infarction with hemodynamic stability, and diabetic nephropathy [1]. These indications rest on strong clinical trial evidence accumulated over four decades.

ALLHAT (N=33,357) compared lisinopril with chlorthalidone and amlodipine in high-risk hypertensive patients. The primary endpoint, fatal coronary heart disease or nonfatal myocardial infarction, did not differ significantly between groups. However, chlorthalidone outperformed lisinopril in reducing combined cardiovascular disease and heart failure endpoints in Black participants, a finding that influenced guideline recommendations about first-line therapy in that population [2].

The GISEN Group's REIN trial (N=352) demonstrated that ramipril (another ACE inhibitor) reduced the rate of GFR decline in patients with nondiabetic proteinuric nephropathy, supporting the broader class effect of ACE inhibitors in CKD management [16]. Lisinopril carries a similar indication for renal protection in diabetic nephropathy based on the Lewis trial (N=409), which showed a 50% reduction in the risk of doubling serum creatinine, end-stage renal disease, or death in patients with type 1 diabetes and nephropathy [17].

For heart failure, the ATLAS trial (N=3,164) compared low-dose versus high-dose lisinopril (2.5 to 5 mg vs. 32.5 to 35 mg daily) and found that higher doses reduced the combined risk of death or hospitalization by 12% (P<0.001) without significant differences in serious adverse events [18]. That trial directly informs the standard clinical practice of titrating lisinopril to the highest tolerated dose in heart failure rather than leaving patients on the minimal starting dose.

Standard adult dosing in hypertension begins at 10 mg once daily, titrated to 20 to 40 mg once daily based on blood pressure response. In heart failure, starting doses are lower (2.5 to 5 mg) with slow titration. Dose adjustment is required for an estimated GFR below 30 mL/min per 1.73 m2. The FDA label specifies a starting dose of 5 mg in patients with creatinine clearance <30 mL/min [1].

Key contraindications include a history of ACE inhibitor-induced angioedema, concurrent use of aliskiren in diabetic patients, and pregnancy. The risk of fetal harm from ACE inhibitors in the second and third trimesters is well established; the FDA classifies lisinopril as category D (now mapped to specific risk language under the PLLR) for those trimesters [1]. Potassium monitoring is appropriate in patients on concurrent potassium-sparing diuretics or in those with CKD, given the risk of hyperkalemia.

Side Effects Mississippi Patients Ask About Most

The most common adverse effect is a dry, persistent cough, which occurs in 5% to 20% of patients and is a class effect of all ACE inhibitors due to bradykinin accumulation [19]. Angioedema, though rare (0.1% to 0.7% incidence), can be life-threatening and is more common in Black patients than in white patients based on ALLHAT subgroup data [2]. Any patient who develops lip, tongue, or throat swelling should stop lisinopril immediately and seek emergency care.

Hyperkalemia is a clinically meaningful risk in patients with CKD or diabetes, particularly when lisinopril is combined with potassium supplements, trimethoprim, or NSAIDs. A baseline and follow-up basic metabolic panel at 2 to 4 weeks after initiation or dose change is standard practice recommended by the AHA [12].

Renal function changes after initiating an ACE inhibitor are expected. A rise in serum creatinine of up to 30% from baseline within the first two weeks is generally acceptable and does not require discontinuation, according to established clinical guidance [20]. Larger or continued rises warrant nephrology consultation.

Practical Cost-Minimization Strategy for Mississippi Patients

The cheapest legitimate route to lisinopril in Mississippi follows a clear sequence. Step one: confirm whether your insurance plan (commercial, Medicare Part D, or employer) covers generic lisinopril at Tier 1. If yes, pay the copay, which is typically $0 to $10. Step two: if uninsured or if Medicaid does not cover the specific product, compare GoodRx, RxSaver, and Blink Health prices at pharmacies near you before filling. Step three: if $8 per month is still a barrier, ask your provider about a NeedyMeds patient assistance program or a 503A compounding pharmacy that partners with a charitable dispensing program.

Walmart's $4 generic program covers lisinopril at participating Mississippi locations [4]. Kroger's prescription savings club offers similarly low prices for a small annual membership fee. Neither program requires insurance, a discount card, or a prior authorization.

For Mississippi Medicaid patients whose prescriber determines that lisinopril is specifically necessary (rather than a formulary ACE inhibitor), the PA process typically requires the prescriber to document at least one trial of a preferred ACE inhibitor or a clinical contraindication to the preferred agent. PA decisions from Mississippi Division of Medicaid are generally issued within 3 business days for non-urgent requests [5].

The AHA's "Get With The Guidelines" initiative has repeatedly cited medication affordability as a top driver of non-adherence in hypertensive patients. Their 2023 hypertension scientific statement notes: "Cost-related non-adherence affects an estimated 8% of U.S. adults with hypertension annually and is associated with a 35% increase in cardiovascular events over 5 years." [12]. At $8 per month cash-pay or less, lisinopril stands as one of the least likely drugs to cause cost-related non-adherence in Mississippi if patients know their options.